日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Can evolutionary therapy be applied in non-small cell lung cancer?

进化疗法能否应用于非小细胞肺癌?

Jansén-Storbacka, Laura R; Honasoge, Kailas S; Molnárová, Eva; Soboleva, Arina; Agema, Bram C; Paats, Marthe S; Moes, Dirk Jan A R; Veerman, G D Marijn; Barbaro, Alethea B T; Dobbe, Roel; Grossmann, Irene; Azimi, Sepinoud; Mathijssen, Ron H J; Dingemans, Anne-Marie C; Staňková, Kateřina

Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives

帕博利珠单抗不同给药方案的生物等效性:现状与展望

Malmberg, Ruben; Agema, Bram C; Hofman, Maaike M; Oosterveld, Stefani; Bins, Sander; Dumoulin, Daphne W; Joosse, Arjen; Aerts, Joachim G J V; Debets, Reno; Koch, Birgit C P; van der Veldt, Astrid A M; van Leeuwen, Roelof W F; Mathijssen, Ron H J

Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology

更正:从前瞻性评估到实践:肿瘤学中基于模型的剂量优化

Agema, Bram C; Koch, Birgit C P; Mathijssen, Ron H J; Koolen, Stijn L W

From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology

从前瞻性评估到实践:基于模型的肿瘤剂量优化

Agema, Bram C; Koch, Birgit C P; Mathijssen, Ron H J; Koolen, Stijn L W

Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study

在乳腺癌患者中实施基于模型的精准他莫昔芬治疗:一项前瞻性干预研究

van Nijnatten, Ruben Y M; Buijs, Sanne M; Agema, Bram C; Fischer, Raphaël M J; Moghaddam-Helmantel, Inge Ghobadi; Contant, Caroline M E; de Jongh, Felix E; Huijben, Auke M T; Kop, Manon; van der Padt-Pruijsten, Annemieke; Zuetenhorst, Hanneke J M; van Schaik, Ron H N; Koch, Birgit C P; Jager, A; Koolen, Stijn L W; Mathijssen, Ron H J

"…I feel like I am just staying here waiting for death": A qualitative study of the lived experiences of people with advanced illness in refugee settlements in Uganda

“……我觉得自己只是待在这里等待死亡”:一项关于乌干达难民营中晚期疾病患者生活经历的定性研究

Song, Ning; Aduro-Agema, Agatha; Namisango, Eve; Aroussi, Sahla; Guo, Ping; Leng, Mhoira; Ebenso, Bassey; Burke, Shaunna; Opia, Vicky; Rabonye, Raphael; Mutoto, Emmanuel; Muehlensiepen, Felix; Kaade, Hanna; Rosa, William E; Asuquo, Eme; Powell, Richard A; Allsop, Matthew J

Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling

利用模型集成方法选择最佳药代动力学模型以实现基于先验模型的精准给药

Agema, Bram C; Kocher, Tolra; Öztürk, Ayşenur B; Giraud, Eline L; van Erp, Nielka P; de Winter, Brenda C M; Mathijssen, Ron H J; Koolen, Stijn L W; Koch, Birgit C P; Sassen, Sebastiaan D T

Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and over

老年医学联合管理对85岁及以上住院心脏病患者预后的影响

Raijmann, Renee C M A; Koek, Huiberdina L; Emmelot-Vonk, Marielle H; Swaving, Joost G E; Agema, Willem R P; Kerckhoffs, Angèle P M; Keijsers, Carolina J P W

Improving the tolerability of osimertinib by identifying its toxic limit

通过确定奥希替尼的毒性极限来提高其耐受性。

Agema, Bram C; Veerman, G D Marijn; Steendam, Christi M J; Lanser, Daan A C; Preijers, Tim; van der Leest, Cor; Koch, Birgit C P; Dingemans, Anne-Marie C; Mathijssen, Ron H J; Koolen, Stijn L W

Relationship between mean volume voided and incontinence in children with overactive bladder treated with solifenacin: post hoc analysis of a phase 3 randomised clinical trial

索利那新治疗儿童膀胱过度活动症后平均排尿量与尿失禁的关系:一项3期随机临床试验的事后分析

Snijder, Robert; Bosman, Brigitte; Stroosma, Otto; Agema, Marja